• Title of article

    Peroxisome proliferator-activated receptor gamma activation decreases neuroinflammation in brain after stress in rats

  • Author/Authors

    Borja Garc?a-Bueno، نويسنده , , José L.M. Madrigal، نويسنده , , Ignacio Lizasoain، نويسنده , , Mar?a A. Moro، نويسنده , , Pedro Lorenzo، نويسنده , , Juan C. Leza، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2005
  • Pages
    10
  • From page
    885
  • To page
    894
  • Abstract
    Background A growing body of evidence has demonstrated that peroxisome proliferator-activated receptor γ (PPARγ) play a role in brain inflammatory conditions because various PPARγ ligands inhibit proinflammatory mediators, such as cytokines (tumor necrosis factor α [TNFα]) and inducible nitric oxide synthase (NOS-2). As has been previously shown, immobilization stress and stress-related neuropsychologic conditions are followed by accumulation of oxidative/nitrosative mediators in brain after the release of cytokines, nuclear factor κB activation, and NOS-2 and cyclooxygenase 2 (COX-2) expression in the brain. Methods To assess whether PPARγ activation can modify the accumulation of oxidative/nitrosative species seen in brain after stress, and to study the mechanisms by which this effect is achieved, young-adult male Wistar rats (control and immobilized during 6 hours) were injected (IP) with the high-affinity ligand rosiglitazone (RS) at the onset of stress. Results Stress increased PPARγ expression in cortical neurons and glia as assessed by Western blot and immunohistochemistry. In stressed animals, RS (1–3 mg/kg) decreased stress-induced increases in NOS-2 activity. On the other hand, the PPARγ ligand decreased stress-induced malondialdehyde (an indicator of lipid peroxidation) accumulation in cortex and prevented oxidation of the main antioxidant glutathione. The mechanisms involved in the antioxidative properties of RS in stress involve nuclear factor KB blockade (by preventing stress-induced IκBα decrease) and inhibition of TNFα release in stressed animals. At the doses tested, RS did not decrease COX-2 expression and prostaglandin E2 release during stress. Finally, RS also decreased chronic (repeated immobilization for 21 days) stress-induced accumulation of oxidative/nitrosative mediators. Conclusions Taken together, these findings suggest a role for this antiinflammatory pathway in the brain response to stress and the possibility of pharmacologic modulation for preventing accumulation of oxidative/nitrosative species and subsequent brain damage in stress-related neuropsychologic conditions.
  • Keywords
    Oxidative status , Neuroinflammation , STRESS , rosiglitazone
  • Journal title
    Biological Psychiatry
  • Serial Year
    2005
  • Journal title
    Biological Psychiatry
  • Record number

    502632